Live Breaking News & Updates on Transgenomic inc

Stay informed with the latest breaking news from Transgenomic inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Transgenomic inc and stay connected to the pulse of your community

Genetic Disease Diagnostic Market: Growing incidences of genetic disorders across the globe to drive the market

The genetic disease diagnostic market is anticipated to present substantial growth across the forecast period of 2021-2031 on the back of the rising prevalence of genetic diseases around the world.

United-states , Canada , America , Rohit-bhisey , Asia-pacific , Biosystems-inc , Veterinary-vaccines-market-developers , Celera-group , Abbott-inc , Perkinelmer-inc , Transparency-market-research , Transgenomic-inc

Pharmacogenomics Market Size to Reach USD 14590 Million by 2028 at a CAGR of 9.3%

BANGALORE, India, April 5, 2022 /PRNewswire/ -- The Global Pharmacogenomics Market is Segmented by Type (Polymerase Chain Reaction (PCR), Microarray, Sequencing), by Application (Cardiovascular

Bangalore , Karnataka , India , United-states , America , Kostenloser-wertpapierhandel , Assurex-health-inc , Linkedin , Bioinformatics-services , Twitter , Teva-pharmaceutical-industries-ltd , Astrazeneca

Genetic Analyzer Systems Market Global Industry Trends, Statistics, Competition Strategies, Revenue

The global Genetic Analyzer Systems market is replete with new growth opportunities and expansion avenues. There has been an increase in the use of products and services falling under the ambit of Genetic Analyzer Systems, giving a thrust to the growth of the global Genetic Analyzer Systems market. The unprecedented...

Australia , Japan , Dubai , Dubayy , United-arab-emirates , United-states , Brazil , China , Luxembourg , Canada , Russia , Dublin

Retaining Analysts Views in Focus: Transgenomic (NASDAQ:TBIO), Workday (NYSE:WDAY)


Transgenomic, Inc. (NASDAQ:TBIO) [Trend Analysis] moved down reacts as active mover, shares a loss -10.81% to trade at $0.66 and the percentage gap between open changing to regular change was -5.39%.
Transgenomic, Inc. (TBIO) reported that a licensing contract with leading Canadian laboratory services provider LifeLabs, which has selected Transgenomic’s ICE COLD-PCR (ICP) technology as its mutation enrichment platform for cancer testing. The three-year, renewable contract includes a non-exclusive license to the ICP technology in Canada. Separately, Transgenomic also reported issuance of a new Canadian patent for ICP.
“LifeLabs is among the largest laboratory service providers in North America, and we view their adoption of ICE COLD-PCR as a key validation of both the technology and our commercial model that focuses on licensing to a wide variety of molecular diagnostics partners worldwide,” commented Paul Kinnon, President and Chief Executive Officer of Transgenomic.

United-states , Canada , America , Canadian , Paul-kinnon , Transgenomic-inc , Workday-inc , Nasdaq , North-america , Chief-executive-officer , ஒன்றுபட்டது-மாநிலங்களில் , கனடா

Genetic Analyzer Systems Sales banking on Increased Government Funding


Published: Apr 01, 2021
Unwavering R&D initiatives is compelling government entities to sanction research projects incorporating advanced genetic analyzer systems
Fact.MR, Rockville MD: The ongoing study on genetic analyzer systems market being conducted by Fact.MR forecasts an optimistic outlook through 2021 and beyond. The novel coronavirus pandemic provided additional tailwinds through FY 2020-21, as healthcare experts were extensively engaged in discovering key breakthroughs to combat the deadly virus.
Prior to the pandemic’s onset, the market was already posting impressive gains, majorly underpinned by unceasing research initiatives by multiple entities. For instance, the Department of Biotechnology (DBT) in India initiated the Genome India Project (GIP) on 3

Germany , Japan , Dubai , Dubayy , United-arab-emirates , United-states , India , United-kingdom , California , Russia , Dublin , Ireland

Worldwide Pharmacogenomics Industry to 2030 - Featuring 23andMe, Abbott Laboratories & Admera Health Among Others


Share this article
Share this article
ResearchAndMarkets.com's offering.
The global pharmacogenomics market will reach $12.83 billion by 2030, growing by 8.1% annually over 2020-2030 driven by increase in adoption of personalized medicine and surge in usage of pharmacogenomics for drug discovery and development amid COVID-19 pandemic.
Highlighted with 88 tables and 83 figures, this 181-page report "Global Pharmacogenomics Market 2020-2030 by Service (Genotyping, SNP, Diagnostics), Technology (PCR, Microarray, Sequencing, Electrophoresis, MS), Application, End User, and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire global pharmacogenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

Australia , United-states , United-kingdom , Brazil , China , Czech-republic , Austria , Dublin , Ireland , Russia , Sri-lanka , Mexico

Outlook on the Pharmacogenomics Global Market to 2030 - Trend Forecasts and Growth Opportunities


Geographically, the following regions together with the listed national/local markets are fully investigated:
APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
North America (U.S., Canada, and Mexico)
South America (Brazil, Chile, Argentina, Rest of South America)
MEA (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Service, Technology, and Application over the forecast years are also included.

Australia , United-states , United-kingdom , Brazil , China , Czech-republic , Austria , Dublin , Ireland , Russia , Sri-lanka , Mexico

Mendelian Disorders Testing Market Shows A Rapid Growth | Industry Trends, Size, Key Players, COVID-19 Impact, Forecast till 2023

Mendelian Disorders Testing Market Shows A Rapid Growth | Industry Trends, Size, Key Players, COVID-19 Impact, Forecast till 2023
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

United-states , India , Switzerland , Americans , Akash-anand , Market-research-consulting-services , Biosystems-inc , Celera-group , Perkinelmer-inc , Market-research-future , Research-newswire , Research-report